134 related articles for article (PubMed ID: 32977199)
1. Isolation, identification, and characterization of potential impurities of doramectin and evaluation of their insecticidal activity.
Zhang Q; Cheng Y; Yang J; Zheng C; Lu X
J Pharm Biomed Anal; 2020 Nov; 191():113600. PubMed ID: 32977199
[TBL] [Abstract][Full Text] [Related]
2. Isolation, identification and characterization of potential impurities of anidulafungin.
Zhao L; Wang Q; Bie Y; Lu X
J Pharm Biomed Anal; 2017 Jul; 141():192-199. PubMed ID: 28448888
[TBL] [Abstract][Full Text] [Related]
3. Four process-related potential new impurities in ticagrelor: Identification, isolation, characterization using HPLC, LC/ESI-MS(n), NMR and their synthesis.
Kumar N; Devineni SR; Gajjala PR; Gupta DK; Bhat S; Kumar R; Dubey SK; Kumar P
J Pharm Biomed Anal; 2016 Feb; 120():248-60. PubMed ID: 26760243
[TBL] [Abstract][Full Text] [Related]
4. Potential impurities of anxiolytic drug, clobazam: Identification, synthesis and characterization using HPLC, LC-ESI/MS
Kumar N; Devineni SR; Dubey SK; Kumar P
J Pharm Biomed Anal; 2017 Apr; 137():268-278. PubMed ID: 28183048
[TBL] [Abstract][Full Text] [Related]
5. Isolation and structural characterization of eight impurities in aztreonam.
Li Y; Yuan M; Ding D; Jiang X; Ye Q; Guo F
J Pharm Biomed Anal; 2022 Feb; 210():114587. PubMed ID: 35026590
[TBL] [Abstract][Full Text] [Related]
6. Isolation, structure characterization and quantification of related impurities in asperosaponin VI.
Ji D; Liu YF; Wang QH; Zhang CF; Yang ZL
Chin J Nat Med; 2013 Jul; 11(4):419-26. PubMed ID: 23845554
[TBL] [Abstract][Full Text] [Related]
7. Characterization of two unknown impurities in roxithromycin by 2D LC-QTOF/MS/MS and NMR.
Wang J; Zhou J; Xu Y; Zhu B; Jin Y
J Pharm Biomed Anal; 2020 May; 184():113196. PubMed ID: 32113121
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of novel process-related impurities in empagliflozin.
Chen Y; Li H; Hong H; Tao H; Peng X; Xu G
J Pharm Biomed Anal; 2021 May; 198():114001. PubMed ID: 33735784
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, isolation, identification and characterization of new process-related impurity in isoproterenol hydrochloride by HPLC, LC/ESI-MS and NMR.
Kumar N; Devineni SR; Gajjala PR; Dubey SK; Kumar P
J Pharm Anal; 2017 Dec; 7(6):394-400. PubMed ID: 29404065
[TBL] [Abstract][Full Text] [Related]
10. Identification, separation and characterization of process-related impurities of bifendate derivative (DB-6), an investigational agent combating acute liver failure.
Ye W; Yang Y; Wang G; Luo Y; Chen L
J Chromatogr Sci; 2015; 53(5):716-24. PubMed ID: 25238768
[TBL] [Abstract][Full Text] [Related]
11. Isolation, identification, characterization, synthesis and quality control strategy of new process-related impurities in ambrisentan.
Feng WD; Zhuo SM; Zhang FL
J Pharm Biomed Anal; 2019 Feb; 165():325-337. PubMed ID: 30579233
[TBL] [Abstract][Full Text] [Related]
12. Isolation, identification and characterization of two novel process-related impurities in olanzapine.
Zhuang T; Zhang W; Cao L; He K; Wang Y; Li J; Chen L; Liu B; Zhang G
J Pharm Biomed Anal; 2018 Apr; 152():188-196. PubMed ID: 29414012
[TBL] [Abstract][Full Text] [Related]
13. Identification, synthesis and structural confirmation of process-related impurities in proparacaine hydrochloride.
Yang Z; Zhao J; Feng Y; Lei Y; Liu D; Qin F; Zheng J; Wang S
J Pharm Biomed Anal; 2020 Oct; 190():113497. PubMed ID: 32798917
[TBL] [Abstract][Full Text] [Related]
14. Stability profiling of anti-malarial drug piperaquine phosphate and impurities by HPLC-UV, TOF-MS, ESI-MS and NMR.
Yan F; Liu J; Zeng X; Zhang Y; Hang T
Malar J; 2014 Oct; 13():401. PubMed ID: 25311421
[TBL] [Abstract][Full Text] [Related]
15. HPLC analysis, semi-preparative HPLC preparation and identification of three impurities in salidroside bulk drug.
Peng Y; Luo J; Lu Q; Chen X; Xie Y; Chen L; Yang W; Du S
J Pharm Biomed Anal; 2009 Apr; 49(3):828-32. PubMed ID: 19167183
[TBL] [Abstract][Full Text] [Related]
16. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
[TBL] [Abstract][Full Text] [Related]
17. Isolation and structural elucidation of two impurities from a diacerein bulk drug.
Ashok C; Golak M; Adwait D; Krishna V; Himani A; Umesh P; Amol G; Srinivas S; Sharad M; Deepali J; Atul C
J Pharm Biomed Anal; 2009 Feb; 49(2):525-8. PubMed ID: 19131202
[TBL] [Abstract][Full Text] [Related]
18. Identification of Novel Impurity of Ziprasidone.
Murkute SR; Singh GP; Vasantharaju SG; Bhat K; Godbole HM; Upadhyay PR; Trivedi A
J Pharm Biomed Anal; 2022 Jan; 207():114416. PubMed ID: 34678557
[TBL] [Abstract][Full Text] [Related]
19. Isolation, identification and structure elucidation of two novel process-related impurities of retigabine.
Zhang D; Song X; Su J
J Pharm Biomed Anal; 2014 Oct; 99():22-7. PubMed ID: 25047423
[TBL] [Abstract][Full Text] [Related]
20. Identification, isolation and characterization of process-related impurities in Rizatriptan benzoate.
Raj TJ; Bharathi Ch; Kumar MS; Prabahar J; Kumar PN; Sharma HK; Parikh K
J Pharm Biomed Anal; 2009 Jan; 49(1):156-62. PubMed ID: 19056198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
